摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<(R)-1'-phenyl-2'-hydroxyethyl>-(1S)-methylenecyclopropanecarboxamide | 127103-94-0

中文名称
——
中文别名
——
英文名称
N-<(R)-1'-phenyl-2'-hydroxyethyl>-(1S)-methylenecyclopropanecarboxamide
英文别名
(1S)-N-[(1R)-2-hydroxy-1-phenylethyl]-2-methylidenecyclopropane-1-carboxamide
N-<(R)-1'-phenyl-2'-hydroxyethyl>-(1S)-methylenecyclopropanecarboxamide化学式
CAS
127103-94-0
化学式
C13H15NO2
mdl
——
分子量
217.268
InChiKey
BCLQUHIPAQVTFV-RYUDHWBXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    通过二酰基过氧化物的光解合成β-环丙基丙氨酸。
    摘要:
    [反应:参见正文] 254纳米(无溶剂)衍生自环丙烷羧酸和l-天冬氨酸的纯净(不溶剂)不对称二酰基过氧化物的光解以合理的收率生成了受保护的β-环丙基丙氨酸。通过这种方法,可以合成抗肿瘤药物贝洛糖素A的关键成分的正交保护的3-(反式-2-氨基环丙基)丙氨酸(21)和牙买加呕吐病的病原体受保护的次糖苷A(26)。中间取代的环丙基自由基的偶联主要在保留构型的情况下进行(dr>或= 95:5)。
    DOI:
    10.1021/ol035859a
  • 作为产物:
    描述:
    参考文献:
    名称:
    (R)-(-)-和(S)-(+)-Synadenol:抗病毒作用的合成,绝对构型和对映选择性。
    摘要:
    描述了(R)-(-)-和(S)-(+)-香豆酚(1a和2a,95-6%ee)的合成。用腺苷脱氨酶将消旋的西地那醇(1a + 2a)脱氨基,得到(R)-(-)-synadenol(1a)和(S)-(+)-次黄嘌呤衍生物5。乙酰化后者化合物,得到乙酸酯6.与N,N-二甲基氯亚甲基氯化铵制得6-氯嘌呤衍生物7。氨解提供了(S)-(+)-synadenol(2a)。通过两种方法确定1a的绝对构型:(i)由(R)-亚甲基环丙烷羧酸(8)合成,以及(ii)(-)-香豆酚盐酸盐单晶的X射线衍射。外消旋的亚甲基环丙烷羧酸(10)通过描述的方法的改变而拆分。将R-对映异构体8转化为乙酯13,将其溴化,得到邻二溴化物14。用二异丁基氢化铝还原,然后得到醇15,将其乙酰化为相应的乙酸酯16。用16的腺嘌呤烷基化消除过程产生乙酸酯17和18。用氨脱保护得到R的Z-和E-异构体1a和19的混合物。 -配置。通过手性
    DOI:
    10.1021/jm980323u
点击查看最新优质反应信息

文献信息

  • Studies on the Inactivation of Bovine Liver Enoyl-CoA Hydratase by (Methylenecyclopropyl)formyl-CoA:  Elucidation of the Inactivation Mechanism and Identification of Cysteine-114 as the Entrapped Nucleophile
    作者:Srikanth Dakoji、Ding Li、Gautam Agnihotri、Hui-qiang Zhou、Hung-wen Liu
    DOI:10.1021/ja011226k
    日期:2001.10.1
    (R)- and (S)-diastereomers of MCPF-CoA to examine the stereoselectivity of this inactivation. Both compounds were shown to be competent inhibitors for bovine liver ECH with nearly identical second-order inactivation rate constants (k(inact)/K(I)) and partition ratios (k(cat)/k(inact)), indicating that the inactivation is nonstereospecific with respect to ring cleavage. The inhibitor, upon incubation
    (亚甲基环丙基)甲酰辅酶 A (MCPF-CoA) 是一种天然氨基酸(亚甲基环丙基)甘酸的代谢物,对牛肝烯酰辅酶 A 合酶 (ECH) 的抑制特性进行了表征。我们之前已经证明 MCPF-CoA 专门针对 ECH,它催化 alpha,beta-不饱和烯酰-CoA 底物可逆地合为相应的 β-羟酰基-CoA 产物。在这里,我们合成了 MCPF-CoA 的 (R)-和 (S)-非对映异构体,以检查这种失活的立体选择性。两种化合物均被证明是牛肝 ECH 的有效抑制剂,具有几乎相同的二级失活速率常数 (k(inact)/K(I)) 和分配比 (k(cat)/k(inact)),表明失活在环裂解方面是非立体特异性的。抑制剂,与牛肝 ECH 孵育后,在蛋白质活性位点附近标记胰蛋白酶肽 ALGGGXEL,其中 X 是共价修饰的氨基酸。牛肝 ECH 基因的克隆和序列分析揭示了被 MCPF-CoA 捕获的氨基酸残基的身份为
  • Lai, Ming-Tain; Liu, Hung-Wen, Journal of the American Chemical Society, 1990, vol. 112, # 10, p. 4034 - 4035
    作者:Lai, Ming-Tain、Liu, Hung-Wen
    DOI:——
    日期:——
  • Mechanistic study on the inactivation of general acyl-CoA dehydrogenase by a metabolite of hypoglycin A
    作者:Ming Tain Lai、Li Da Liu、Hung Wen Liu
    DOI:10.1021/ja00019a040
    日期:1991.9
    General acyl-CoA dehydrogenase (GAD) is a flavin-dependent (FAD) enzyme that catalyzes the oxidation of a fatty acyl-CoA to the corresponding alpha,beta-enolyl-CoA. When GAD is exposed to (methylenecyclopropyl)acetyl-CoA (MCPA-CoA), a metabolite of hypoglycin A that is the causative agent of Jamaican vomiting sickness, time-dependent inhibition occurs with concomitant bleaching of the active-site FAD. The inactivation mechanism is generally believed to be initiated by C-alpha anion formation followed by ring fragmentation and the covalent modification of FAD. However, formation of a cyclopropyl radical intermediate through one-electron oxidation followed by ring opening and then radical recombination to yield a modified FAD is an appealing alternative. As described herein, studies of the inactivation of GAD by (1S)- and (1R)-MCPA-CoA bearing a stereospecific tritium label at C-alpha have provided direct evidence suggesting that C-alpha proton abstraction occurs during inactivation and the two diastereomers of MCPA-CoA bind to the same locus in the active site of GAD. Despite the fact that the inactivations mediated by (1R)- and (1S)-MCPA-CoA proceed at different rates, the observed partition ratios are almost identical. Using [alpha,alpha-H-2(2)]MCPA-CoA as inhibitors, we have found that the sluggish inactivation observed for (1S)-MCPA-CoA is not due to mechanistic rerouting, but is instead a result of the retardation of the initial deprotonation step. Thus, the equivalent partition ratios found in these studies clearly indicate that inactivation by either (1R)- or (1S)-MCPA-CoA follows the same chemical course. Such a lack of stereospecificity for the bond rupture at C-beta of MCPA-CoA in the enzyme active site suggests that the ring-opening step leading to inactivation is likely a spontaneous event. Since the rearrangement of alpha-cyclopropyl radicals to ring-opened alkyl radicals is extremely rapid, the ring cleavage induced by an alpha-cyclopropyl radical may bypass the chiral discrimination normally imposed by the enzyme. Thus, the mechanistic insights deduced from this study support our early notion that inactivation of GAD by MCPA-CoA is likely to proceed through a radical mechanism.
  • LAI, MING-TAIN;LIU, HUNG-WEN, J. AMER. CHEM. SOC., 112,(1990) N0, C. 4034-4035
    作者:LAI, MING-TAIN、LIU, HUNG-WEN
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫